Maynard Ryan D 4
4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Nov 14, 2024
Insider Transaction Report
Form 4
Maynard Ryan D
Director
Transactions
- Exercise/Conversion
Common Stock
2024-11-12$7.45/sh+50,000$372,500→ 57,500 total - Sale
Common Stock
2024-11-12$10.06/sh−50,000$503,000→ 7,500 total - Exercise/Conversion
Stock Option (right to buy)
2024-11-12−50,000→ 0 totalExercise: $7.45From: 2016-02-16Exp: 2025-02-15→ Common Stock (50,000 underlying)
Footnotes (5)
- [F1]Represents an exercise of stock options prior to the 10-year expiration date of such options.
- [F2]Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
- [F3]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $10.05 and $10.105.
- [F4]These options became exercisable in four equal quarterly installments of 12,500 each following the date of grant, which was February 16, 2015.
- [F5]Such aggregate number reflects the remainder of such stock options granted on February 16, 2015, but does not include any other stock options held by such Reporting Person.